Brainstorm cell therapeutics to provide corporate mid-year update on nurown program

A conference call and webcast will be held monday, july 8, at 8:00 a.m. eastern time new york , july 1, 2024 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that it will hold a mid-year corporate update to discuss recent positive developments in the nurown® program on monday, july 8, at 8:00 a.m.
BCLI Ratings Summary
BCLI Quant Ranking